 eFFECTOR Therapeutics Inc NASDAQ: EFTR is trading higher Monday after Cantor Fitzgerald initiated coverage on the stock. Cantor Fitzgerald analyst Louise Chen initiated coverage on eFFECTOR Therapeutics with an Overweight rating and announced a price target of 50. 